Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Medpace Holdings Inc (NQ: MEDP )

340.98 -0.84 (-0.25%)
Streaming Delayed Price Updated: 12:34 PM EST, Nov 22, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 115,775
Open 340.45
Bid (Size) 339.99 (6)
Ask (Size) 342.52 (6)
Prev. Close 341.82
Today's Range 339.68 - 350.00
52wk Range 268.80 - 459.77
Shares Outstanding 30,998,636
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MEDPACE ALERT: Bragar Eagel & Squire, P.C. is Investigating Medpace Holdings, Inc. on Behalf of Medpace Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire

Performance

YTD
+11.58%
+11.58%
1 Month
+4.42%
+4.42%
3 Month
-11.74%
-11.74%
6 Month
-12.70%
-12.70%
1 Year
+23.16%
+23.16%

More News

Read More
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
$100 Invested In This Stock 5 Years Ago Would Be Worth $400 Today
Via Benzinga
Insights Ahead: Medpace Hldgs's Quarterly Earnings
Via Benzinga
Bragar Eagel & Squire, P.C. Is Investigating Aviat, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MEDP Investors Have Opportunity to Join Medpace Holdings, Inc. Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
This McDonald's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday
Via Benzinga
Exploring Medpace Hldgs's Earnings Expectations
Via Benzinga
Earnings Preview For Medpace Hldgs
Via Benzinga
Examining the Future: Medpace Hldgs's Earnings Outlook
Via Benzinga
A Look at Medpace Hldgs's Upcoming Earnings Report
Via Benzinga
NASDAQ: MEDP Investigation Alert: Kessler Topaz Meltzer & Check, LLP Encourages Medpace Holdings, Inc. (NASDAQ: MEDP) Investors with Significant Losses to Contact the Firm
From Kessler Topaz Meltzer & Check, LLP
Via Business Wire
Why Is Medpace Stock Diving On Tuesday?
Via Benzinga
How Medpace Just Blew Up Expectations For Double-Digit Sales Growth In 2025
Via Investor's Business Daily
Sherwin-Williams Posts Weak Results, Joins Logitech And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Medpace Hldgs
Via Benzinga
Looking Into Medpace Hldgs's Recent Short Interest
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why iRhythm Technologies Shares Are Trading Higher By Over 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Medpace Holdings, Inc. Reports Third Quarter 2024 Results
From Medpace Holdings, Inc.
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating MaxLinear, Centuri, Medpace, and Franklin and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
MEDP INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces an Investigation into Medpace Holdings, Inc. and Encourages Investors to Contact the Firm
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
Bragar Eagel & Squire, P.C. Is Investigating Cardlytics, Medpace, Customers Bancorp, and Ibotta and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.